The Royal Pharmaceutical Society (RPS) has appointed Dr Anthony Cox from the University of Birmingham as the new chair of its Education and Standards Committee.
Anthony is Head of the School of Pharmacy and a Reader in Clinical Pharmacy and Drug Safety. He has previously been a member of the English Pharmacy Board and is a
Fellow of the RPS.
The Education and Standards Committee provides expert advice and makes recommendations to the RPS Education and Professional Development directorate, reporting
directly to the RPS Assembly.
Dr Anthony Cox said: "I'm looking forward to working with the committee during this vitally important time for the education of the profession at all levels, and
delighted to support the RPS in continuing to develop and deliver its important role in defining and assuring post-registration standards of pharmacy practice."
Pharmacy technicians will soon be recognised as fully regulated healthcare professionals in North Ireland.
Work has begun to bring pharmacy technicians under statutory regulation by the Pharmaceutical Society of Northern Ireland, health minister Robin Swann has announced.
The public consultation was launched in March 2022 on a proposal to introduce statutory regulation of the Pharmacy Technician workforce in Northern Ireland.
The minister said: "This will be a key enabler to enhancing the contribution that pharmacy technicians can make to the delivery of healthcare across all settings.
It will allow the regulator to strengthen its role in protecting patients and promoting high standards, thereby enhancing the public's confidence and trust in
pharmacy practice."
He added: "While there are many practical issues to be worked through with stakeholders, and legislative change required, I have now instructed my Department's
officials to develop a detailed project plan to bring about the statutory regulation of pharmacy technicians by the Pharmaceutical Society of Northern Ireland".
More than 80 per cent of pharmacy organisations have received the Department for Work and Pensions (DWP) functionality for Real Time Exemption Checking (RTEC).
The NHS Business Services Authority (NHSBSA) has confirmed RTEC has been rolled out gradually, in phases. Contractors first received RTEC for use with processing
NHSBSA exemptions.
RTEC allows pharmacy teams to digitally check if patients are eligible for free NHS prescriptions because they hold a specific exemption. The rollout of the DWP
inclusion in RTEC means patients found to be exempt via RTEC no longer need to complete an exemption declaration on an EPS token, saving time for patients and
pharmacy teams.
David Broome, a community pharmacy contractor in Leeds and PSNC regional representative said: "The rollout of the DWP for our pharmacy team has been a positive
development, helping reduce the amount of paperwork that my team and patients have to deal with and in turn the environmental impact of our operations. Whereas I
used to send my paperwork bundle to the NHSBSA in a large box, I now send this in an envelope!"
Contractors can access and confirm their acceptance of the RTEC user agreement via the RTEC registration form in the NHSBSA's Manage Your Service (MYS) portal.
Within the last few weeks, at least six pharmacists have been subjected to interim order applications - either suspended or had significant restrictions
placed upon their registration pending a full 'Fitness to Practise' hearing into serious allegations being made about their prescribing practices, the Pharmacists'
Defence Association (PDA) has found.
It said that there has been a "dramatic increase in action being taken by the pharmacy regulator (GPhC) against pharmacist prescribers associated with certain types
of online prescribing services".
It has warned pharmacist prescribers who work for online pharmacies about the specific risks associated with remote prescribing using a questionnaire-based model,
typically with no direct prescriber/patient interaction.
Common features that underpin the allegations include the following: Overreliance on a patient questionnaire to inform clinical decision making; No patient/prescriber
interaction; Prescribing high risk medicines without adequate safeguards; Inadequate systems and processes leading to inappropriate prescribing; Very high volumes
of prescriptions being authorised in short periods of time; and Prescribers/patient relationship established via an unregulated online portal.
The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees.
Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards
gap compared to white students.
The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve
a fair and equitable education and training experience for the students.
They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group.
Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.
The General Pharmaceutical Council (GPhC) has decided to increase the renewal fees of pharmacists, pharmacy technicians, and pharmacy premises
by 7.5% from April 2024.
The pharmacy technician's renewal fee will see an increase by £9 from £121 to £130, pharmacists fees from £257 to £276, and pharmacy premises from £365 to £392.
The following decision came even despite the renewal fees being frozen for individual registrants since 2019 and for pharmacy premises since 2021.
This move was facilitated through cost savings measures like using financial reserves and downsizing to a smaller office.
However, the council confirmed that the fee hike is due to higher rates of inflation, increase in utility bills and supplier costs.
Duncan Rudkin, Chief Executive and Registrar of the GPhC, said: "We know that these are challenging times and that this increase will come as unwelcome
news to those we regulate. But to be effective in our role of protecting the public we need to make sure the fees we charge cover the cost of regulation
going forward."
The UK government will lay legislation today (13 December 2023) to allow the General Medical Council (GMC) to begin the process of regulating medical
associates to expand their roles in the NHS.
This will support plans to reduce pressure on doctors and GPs and improve access for patients, the Department of Health and Social Care (DHSC) said.
Physician associates (PAs) and anaesthesia associates (AAs) will have the same levels of regulatory oversight and accountability as doctors and other regulated
healthcare professionals once the regulations come into force, which is expected at the end of 2024.
The GMC will design and deliver detailed regulatory processes for registration, education, standards and fitness to practise for both professions.
Community pharmacy contractors eligible under the revised Pharmacy Access Scheme (PhAS) will receive their first of the new monthly payments with the January reconciliation payment due on April 1, 2022.
Details of the revised version of the PhAS that commenced from January 1, was published in August 2021, with contractors receiving letters from the NHS Business
Services Authority (NHSBSA) indicating their eligibility in the Autumn, PSNC said in an update.
Payments under the scheme are dependent on registration on NHSBSA's Manage Your Service (MYS) portal to provide the Community Pharmacist Consultation Service(CPCS).
Meanwhile, the review application window is now open for contractors, which would enable the NHS England and NHS Improvement (NHSE&I) to correct inaccuracies related to a pharmacy's distance criteria/calculation.
A new NHS-funded training course on clinical examination skills has been announced by Health Education England (HEE) for 10,000 community pharmacists.
The training will be provided by CliniSkills and be coordinated by HEE with the Pharmacy Integration Programme at NHS England.
With pre-registration now open to all community pharmacists, the programme will be available from 17th April 2023 and will until March 2024.
It will be delivered online, with optional face-to-face attendance for pharmacists who would find this beneficial.
Pharmacists will be required to complete a module on history taking and identification of serious conditions and can then choose from four optional modules,
which cover the following themes: dermatology; cardiology; paediatrics; and ear, nose and throat.
The training is designed to be complementary to the independent prescribing training and can be completed prior to or after an independent prescribing training
course. It is open to all community pharmacists including those that work part time and locums.
A groundbreaking study analysing data from nearly 600,000 cancer patients in England has shed light on the increased risk of second cancers among breast
cancer survivors.
The research conducted by University of Cambridge in association with the Lancet Regional Health-Europe studied data from over 580,000 female and over 3,500 male
breast cancer survivors diagnosed between 1995 and 2019 using the National Cancer Registration Dataset.
The findings suggest that survivors of breast cancer, the most prevalent cancer in the UK, face a substantially higher risk of developing second primary cancers.
According to the research, female survivors exhibited a twofold increase in the risk of contralateral breast cancer compared to the general population.
The data highlighted an 87 per cent greater risk of endometrial cancer, a 58 per cent greater risk of myeloid leukemia, and a 25 per cent greater risk of ovarian
cancer in female survivors.
The General Pharmaceutical Council's Investigating Committee took decisive action on March 25, 2024, by issuing a warning to Dilsha Kiran Shah,
registration number: 2049787, for her conduct as Superintendent Pharmacist of Jhoots Healthcare Ltd.
Miss Shah's failure to uphold the Medicines Act 1968, specifically in ensuring the proper management of medicinal products, triggered this warning.
The Act mandates supervision in "keeping, preparing, and dispensing medicinal products other than those on a general sale list."
Moreover, pharmacies are inspected on five principles - Governance, Staff, Premises, Services including medicines management, and Equipment and facilities to
meet the right standards.
The alarm was initially raised in August 2021 when a Jhoots Healthcare Ltd pharmacy branch under Miss Shah's supervision operated without a responsible pharmacist.
Despite explicit instructions, pharmacy staff were allegedly instructed to proceed without proper supervision, raising grave concerns regarding patient safety.
Women accounted for 62 per cent of GPhC registrants in 2019, according to the Royal Pharmaceutical Society. Despite representing the majority of pharmacists
in the UK, only 2 per cent of women are pharmacy business owners compared with 13 per cent of men. Also, the majority of senior pharmacy leadership positions are
held by men, with research showing that only 36 per cent of senior pharmacy leaders are women.
Sobha Sharma Kandel, superintendent pharmacist and co-owner of Neem Tree Pharmacy, Abbey Wood, London, quoted these statistics while shedding light on the
representation of female leaders in the field of pharmacy.
So, what is stopping women from reaching leadership positions in the profession? According to Sobha, the barriers hindering female pharmacists from attaining
leadership positions include:
Gender Bias and Stereotypes
Lack of Representation and Role Models
Glass Ceiling and Double Standards
Work-Life Balance Challenges
Imposter Syndrome
Unequal Access to Opportunities
Negotiation and Advocacy Challenges
"There also continue to be gender and ethnicity pay gaps affecting women in pharmacy," said Sobha, who has been advocating for women in pharmacy by being a part
of the Female Pharmacy Leaders Network.
A recent report published by the General Pharmaceutical Council (GPhC) has highlighted a significant increase in the number of registered pharmacists
and pharmacy technicians, indicating the expanding role of these professionals in the UK healthcare system.
As of May 31, 2024, the GPhC register recorded a total of 90,739 pharmacy professionals, up from 90,604 at the end of April 2024.
This includes 64,415 pharmacists and 26,324 pharmacy technicians, maintaining a steady split of 71 per cent pharmacists and 29 per cent pharmacy technicians.
This reflects an overall increase of four pharmacists and 131 pharmacy technicians from the previous month.
The report underscores the critical role of pharmacy professionals in ensuring high-quality patient care and supporting the operational efficiency of pharmacies.
Softtech World is a leading Website development & Designing Company in India. We also specialize in Web designing, eCommerce & business applications. Get your dream website at cheapest price.
For any query, Please write to us at: info@softtechworld.com
Or Call to us at: +91 9999819534
Or Visit at: http://www.softtechworld.com
The General Pharmaceutical Council (GPhC) temporary register which was expected to close on 30 September 2022 will continue for the next two years following a
request from the secretary of state for health and social care.
The temporary register was set up in 2020 after the then secretary of state asked the GPhC to use its emergency powers in order to rapidly register pharmacy
professionals to assist in the national response to the Covid-19 emergency.
The UK government has made this decision, which is referenced in its new 'Plan for Patients' in England to enable health professionals on the temporary registers to
continue to support the health and social care system.
The Government had previously announced that the temporary registers established by the health professional regulators were expected to close on 30 September 2022.
The decision by the UK government to ask the regulators to keep the temporary registers means that pharmacy professionals on GPhC temporary register can continue to
practise.
The General Pharmaceutical Council (GPhC) has revealed it has received 25 whistleblowing disclosures between April 2021 and March 2022.
The pharmacy regulator said, in its annual report, that it has concluded enquiries on 22 disclosures so far with a further three still under review.
"We also concluded two qualifying disclosures that were raised during the previous reporting period," it said, adding: "The action GPhC took included a full
investigation through established fitness to practise processes and follow-up action through its inspection network.
"The former can result in any available outcome throughout the fitness to practise process. The latter can include guidance, a follow-up visit or an unexpected
inspection."
12 concerns were investigated and concluded with no further action. Three were signposted to another organisation. The remaining seven cases were concluded by
sharing information with inspection colleagues for follow up action.
Of the two concerns from the previous reporting period, one was concluded with no further action and the other remains under investigation.
The Council of Pharmaceutical Society NI (PSNI) has introduced an 8-week public consultation on proposed Guidance on Pharmacy Staffing Levels within registered
premises.
The principle-based Guidance seeks to assist Pharmacy Owners and Superintendents to ensure that each pharmacy has enough appropriately skilled and qualified staff
to provide safe and effective pharmacy services to the public. All registered pharmacies will have to meet the standards set out in the Premises Standards, when
commenced.
PSNI said: "The proposed Guidance should also help ensure a working environment that will facilitate pharmacists to meet their professional obligations under the
Professional Standards of Conduct, Ethics and Performance for Pharmacists in Northern Ireland (2016)."
"Whilst other health regulators have primary responsibility for systems regulation outside of regulated premises, we consider that the principles outlined in this
Guidance, will be helpful for managers working with pharmacy teams in different settings."
Pharmacy owners using NHS Business Services Authority (NHSBSA) Manage Your Service (MYS) portal are urged to complete the 2023/24 Community Pharmacy Assurance
Framework (CPAF) screening questionnaire which is available until midnight on Sunday (30 July).
The short screening questionnaire consists of 10 questions. Those who are not yet signed up to MYS will be able to complete the questionnaire online. The questions
will be published on the NHSBSA website shortly.
Once the screening questionnaires have been completed, NHS England will then select a small number of pharmacies for a monitoring visit and/or to complete the full
CPAF questionnaire.
Community Pharmacy England has published a short Briefing on the screening process. As the questions have not changed since 2022/23 the previous briefing is still
relevant.
NHS England has launched a cloud-based platform that links recently-retired consultants, who still hold a licence to practice, with secondary care providers
who need additional help with their waiting lists.
It has been developed to make it easier and more flexible for retired doctors to return to the health service as part of the Long Term Workforce Plan.
NHS chief executive Amanda Pritchard in June 2023 announced the NHS Emeritus pilot scheme, which is expected to help reduce long waits for elective care.
Initially, the scheme will run for a year across England, and if successful, it may be expanded to cover other work areas.
Health Minister Andrew Stephenson commented: "Returning consultants will bring invaluable experience and knowledge, and the new digital platform will match
highly-skilled consultants with the NHS trusts that require their expertise, providing high quality care and alleviating pressures on high demand areas.